Clinical Trial Update: Clinical Estradiol Trial in Women With Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of estradiol in women with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• ESTRADIOL (Estradiol)

Snippet

Sponsor: Bayside Health | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED